click below
click below
Normal Size Small Size show me how
mod 6 Respiratory P2
module 6 Respiratory Part 2
| Term | Definition |
|---|---|
| Asthma: | Chronic airway inflammation causing breathing difficulty. |
| Chronic Obstructive Pulmonary Disease (COPD): | Lung disease causing persistent breathing problems. |
| Obstructive Pulmonary Diseases: | Conditions with narrowed airways blocking airflow. |
| Triggers: | Factors that start or worsen asthma symptoms. |
| Allergens: | Substances that cause allergic reactions. |
| Tobacco Smoke: | Major cause and trigger of lung diseases. |
| Exercise-Induced: | Asthma symptoms triggered by physical activity. |
| Respiratory Infection: | Illnesses that can worsen asthma. |
| Gastroesophageal Reflux Disease (GERD): | Stomach acid backup that can trigger asthma. |
| Air Pollutants: | Harmful substances in air that affect breathing. |
| Emotional Stress: | Feelings that can make asthma worse. |
| Genetics: | Family traits that increase disease risk. |
| Early-Phase Response: | Immediate asthma reaction after exposure. |
| Late-Phase Response: | Delayed, more severe asthma reaction. |
| Bronchospasm: | Sudden tightening of airway muscles. |
| Inflammation: | Swelling and irritation in airways. |
| Airway Hyper-responsiveness: | Overly sensitive airways. |
| Airway Remodeling: | Permanent changes to airway structure. |
| Status Asthmaticus: | Severe, life-threatening asthma attack. |
| FEV₁ (Forced Expiratory Volume in 1 second): | Air exhaled in first second. |
| FVC (Forced Vital Capacity): | Total air exhaled forcefully. |
| Peak Expiratory Flow (PEF): | Maximum breathing out speed. |
| Controllers: | Daily medications to prevent symptoms. |
| Relievers: | Quick-relief medications for attacks. |
| Corticosteroids: | Anti-inflammatory medications. |
| Bronchodilators: | Medications that open airways. |
| β-Adrenergic Agonists: | Bronchodilators that relax airway muscles. |
| Anticholinergics: | Bronchodilators that block nerve signals. |
| Methylxanthines: | Older type of bronchodilator. |
| Antileukotrienes: | Medications blocking inflammation chemicals. |
| Biological Therapy: | Advanced treatment targeting immune system. |
| Metered-Dose Inhaler (MDI): | Pressurized asthma medication device. |
| Dry Powder Inhaler (DPI): | Breath-activated medication device. |
| Spacer: | Attachment to improve inhaler medication delivery. |
| Nebulizer: | Machine that turns liquid medicine into mist. |
| Asthma Action Plan: | Written instructions for managing asthma. |
| Self-Management: | Patient's active role in controlling condition. |
| Chronic Bronchitis: | Long-term cough with mucus (COPD type). |
| Emphysema: | Lung damage causing air trapping (COPD type). |
| Dyspnea: | Shortness of breath. |
| Mucus Hypersecretion: | Excessive mucus production. |
| Hyperinflation: | Over-expanded lungs unable to empty properly. |
| Barrel-Chest: | Rounded chest shape from air trapping. |
| Cor Pulmonale: | Right heart failure from lung disease. |
| Acute Exacerbation of COPD (AECOPD): | Sudden worsening of COPD symptoms. |
| Alpha-1 Antitrypsin (AAT) Deficiency: | Genetic condition causing COPD. |
| Modified Medical Research Council (mMRC) Dyspnea Scale: | Measures breathlessness severity. |
| Long-Term Oxygen Therapy (LTOT): | Continuous oxygen for chronic low oxygen. |
| Pulmonary Rehabilitation: | Comprehensive program to improve lung health. |
| Pursed-Lip Breathing: | Breathing technique to reduce shortness of breath. |
| Diaphragmatic Breathing: | Deep breathing using diaphragm muscle. |
| Huff Coughing: | Technique to clear mucus without tiring. |
| Energy Conservation: | Methods to save energy during daily activities. |